{\rtf1 \ansi 
{\colortbl;
\red0\green0\blue0;
\red255\green255\blue255;
\red255\green0\blue0;
\red0\green255\blue0;
\red0\green0\blue255;
\red0\green255\blue255;
\red255\green0\blue255;
\red255\green255\blue0;
\red0\green0\blue128;
\red0\green128\blue128;
\red0\green128\blue0;
\red128\green0\blue128;
\red128\green0\blue0;
\red128\green128\blue0;
\red128\green128\blue128;
\red192\green192\blue192;
\red170\green170\blue170;
\red85\green85\blue85;
\red14\green86\blue140;
\red37\green37\blue37;
\red33\green33\blue33;
\red119\green119\blue119;
\red238\green238\blue238;
\red20\green93\blue164;
\red246\green246\blue246;
\red255\green255\blue102;
\red80\green80\blue80;
\red51\green51\blue51;
\red181\green79\blue104;
\red204\green204\blue204;
\red151\green151\blue151;
\red21\green137\blue21;
\red255\green248\blue96;
\red106\green144\blue39;
\red254\green254\blue0;
\red56\green124\blue43;
\red0\green114\blue54;
\red112\green112\blue112;
\red247\green247\blue247;
\red107\green107\blue106;
\red232\green233\blue232;
\red249\green249\blue249;
\red223\green223\blue223;
\red239\green239\blue239;
\red236\green236\blue236;
\red187\green187\blue187;
\red255\green255\blue198;
\red249\green250\blue251;
\red228\green231\blue232;
\red214\green9\blue9;
\red255\green255\blue174;
\red190\green190\blue252;
\red233\green233\blue233;
\red240\green240\blue240;
\red105\green105\blue105;
\red227\green227\blue227;
\red61\green61\blue61;
\red218\green218\blue218;
\red214\green78\blue69;
\red61\green61\blue60;
\red250\green222\blue100;
\red183\green242\blue206;
\red255\green194\blue211;
\red255\green255\blue204;
\red255\green204\blue0;
\red118\green118\blue118;
\red255\green210\blue183;
\red182\green231\blue243;
\red203\green203\blue203;
\red245\green245\blue245;
\red229\green243\blue255;
\red179\green218\blue255;
\red153\green153\blue153;
\red71\green120\blue194;
\red240\green248\blue255;
\red127\green127\blue127;
\red204\green255\blue255;
\red120\green162\blue47;
\red251\green252\blue255;
\red72\green72\blue72;
\red190\green195\blue204;
\red208\green208\blue208;
\red239\green122\blue2;
\red214\green214\blue214;
\red102\green0\blue102;
\red185\green185\blue185;
\red188\green41\blue30;
\red190\green237\blue228;
\red243\green243\blue243;
\red24\green140\blue181;
\red89\green89\blue89;
\red86\green86\blue86;
\red16\green58\blue89;
\red255\green204\blue153;
\red23\green94\blue146;
\red172\green172\blue172;
\red9\green56\blue84;
}
{\fonttbl {
\f0 Arial;}{
\f1 Symbol;}{
\f2 Times New Roman;}{
\f3 georgia;}{
\f4 sans-serif;}{
\f5 Source Sans Pro;}{
\f6 serif;}{
\f7 Courier New;}{
\f8 Helvetica;}{
\f9 Knowledge;}
}
{\*\generator Apache XML Graphics RTF Library;}
\fet0 \ftnbj \paperw12240 \paperh15840 \margt1080 \margb1080 \margl1080 \margr1080 \headery720 \footery720 \itap0 \cols2 
\sectd {\header {
{\trowd \ltrrow \trleft0 
\clpadb60 \clpadfb3 \clpadl400 \clpadfl3 \clbrdrt \clbrdrb \brdrcf17 \brdrw20 \brdrs \clbrdrl \trql \clvertalb \clwWidth9380 \cellx9380 
\clpadb60 \clpadfb3 \clpadl400 \clpadfl3 \clbrdrt \clbrdrb \brdrcf17 \brdrw20 \brdrs \clbrdrr \trql \clwWidth700 \cellx10080 
\intbl 
{\b0 \cf1 \f0 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f0 \ul0 \strike0 \i0 \fs18 
}
{\b1 \cf18 \f0 \i0 \fs18 
{\b1 \cf18 \f0 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Bristol\u8211\'3fMyers Squibb Co. v. Merck & Co., Inc., Not Reported in Fed. Supp. (2016)
}
}
{\b0 \cf1 \f0 \ul0 \strike0 \i0 \fs18 
}
}\b0 \cf1 \f0 \ri0 \ul0 \strike0 \i0 \ql \fs18 \li0 \sa0 \sb0 \intbl \cell \intbl 
{\qr \b0 \cf1 \f0 \ri0 \i0 \fs18 \li0 
}\qr \b0 \cf1 \f0 \ri0 \i0 \fs18 \li0 \intbl \cell \row }
{\trowd \lastrow \trleft0 
\clbrdrb \clbrdrl \trql \clwWidth10080 \cellx10080 
\intbl 
{\b0 \cf1 \f0 \ri0 \i0 \ql \fs18 \li0 
}\b0 \cf1 \f0 \ri0 \i0 \ql \fs18 \li0 \intbl \cell \row }}\par }{\footer {
{\trowd \lastrow \trleft0 
\clpadl60 \clpadfl3 \clbrdrt \brdrcf17 \brdrw20 \brdrs \clbrdrb \clbrdrl \trql \clvertalb \clwWidth9300 \cellx9300 
\clpadl60 \clpadfl3 \clbrdrt \brdrcf17 \brdrw20 \brdrs \clbrdrb \clbrdrr \trql \clwWidth700 \cellx10000 
\intbl 
{\b0 \cf17 \f0 \ri0 \i0 \ql \fs20 \li0 
{\b0 \cf17 \f0 \ul0 \strike0 \i0 \fs20 
}
{\*\shppict {\pict \pngblip \picw78 \pich10 \picwgoal1170 \pichgoal150 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}}
{\b0 \cf17 \f0 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u169\'3f 2021 Thomson Reuters. No claim to original U.S. Government Works.
}
}\b0 \cf17 \f0 \ri0 \ul0 \strike0 \i0 \ql \fs20 \li0 \sa0 \sb0 \intbl \cell \intbl 
{\qr \b0 \cf17 \f0 \ri0 \i0 \fs20 \li0 
{\b0 \i0 \ul0 \fs20 \f0 \chpgn }
}\qr \b0 \cf17 \f0 \ri0 \ul0 \strike0 \i0 \fs20 \li0 \intbl \cell \row }}\par }
{\b0 \cf1 \f2 \ri0 \par}\sect\sbknone\pgncont\cols2{\ids0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_document_61}{\*\bkmkend co_document_61}
{\b0 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart Id61a54a00dcf11e6a647af7ccdd8c5d2_Target}{\*\bkmkend Id61a54a00dcf11e6a647af7ccdd8c5d2_Target}
\par 
}
{\b0 \qc \cf1 \f3 \ri0 \i0 \fs20 \li0 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs20 \sa0 \sb100 
2016 WL 1698385
\par 
}
}
{\b0 \qc \cf1 \f3 \ri0 \i0 \fs20 \li0 
{\b0 \qc \cf1 \f3 \ri0 \i0 \fs20 \li0 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Only the Westlaw citation is currently available.
\par 
}
}
}
{\b0 \qc \cf1 \f3 \ri0 \i0 \fs20 \li0 
{\b0 \qc \cf1 \f3 \ri0 \i0 \fs20 \li0 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
United States District Court, D. Delaware.
\par 
}
}
}
{\b0 \qc \cf20 \f3 \ri120 \i0 \fs24 \li120 
{\b0 \qc \cf20 \f3 \ri120 \i0 \fs24 \li120 
{\b0 \qc \cf20 \f3 \ri120 \i0 \fs24 \li120 
{\b0 \cf20 \f3 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
BRISTOL\u8211\'3fMYERS SQUIBB CO., E. R. Squibb & Sons, L.L.C., 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Search/Results.html?query=advanced%3a+OAID(4295877874)&saveJuris=False&contentType=BUSINESS-INVESTIGATOR&startIndex=1&contextData=(sc.Default)&categoryPageUrl=Home%2fCompanyInvestigator&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem" }{\fldrslt 
{\b0 \cf19 \f3 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
Ono Pharmaceutical Co., Ltd.
}}}
{\b0 \cf20 \f3 \ul0 \strike0 \i0 \fs24 \sa0 \sb240 
, and Tasuku Honjo, Plaintiff,
\par 
}
}
{\b0 \qc \cf20 \f3 \ri120 \i0 \fs24 \li120 
{\b0 \cf20 \f3 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
v.
\par 
}
}
{\b0 \qc \cf20 \f3 \ri120 \i0 \fs24 \li120 
{\b0 \cf20 \f3 \ul0 \strike0 \i0 \fs24 \sa240 \sb0 
MERCK & CO., INC. and Merck Sharp & Dohme Corp., Defendant.
\par 
}
}
}
}
{\b0 \qc \cf1 \f2 \ri0 \i0 \fs20 \li0 
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \qc \cf1 \f3 \ri0 \i0 \fs20 \li200 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Civil Action No. 15\u8211\'3f572\u8211\'3fGMS
\par 
}
}
}
{\b0 \cf1 \f3 \i0 \fs20 
{\b0 \qc \cf1 \f3 \ri0 \i0 \fs20 \li200 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
|
\par 
}
}
{\b0 \qc \cf1 \f3 \ri0 \i0 \fs20 \li200 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs20 \sa200 \sb0 
Signed March 29, 2016
\par 
}
}
}
}
{\b1 \cf21 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_attorneysAndLawFirms_61}{\*\bkmkend co_attorneysAndLawFirms_61}
{\b1 \cf21 \f2 \ul0 \strike0 \i0 \fs20 \sa200 \sb200 
Attorneys and Law Firms
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0143000301&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Joseph J. Farnan, Jr.
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0328780701&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Brian E. Farnan
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0411680301&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Michael J. Farnan
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, Farnan LLP, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0418029101&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Andrew Colin Mayo
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, Ashby & Geddes, Wilmington, DE, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0392972301&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Matthew Alan Pearson
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, Akin Gump Strauss Hauer & Feld LLP, Philadelphia, PA, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0326979501&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Angela Verrecchio
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, Pro Hac Vice, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0116122601&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Dianne B. Elderkin
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, Pro Hac Vice, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0370584301&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Emily C. Johnson
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, Pro Hac Vice, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0475362501&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Jason E. Weil
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, Pro Hac Vice, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0441404801&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Jenna M. Pellecchia
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, Pro Hac Vice, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0431639601&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Melissa R. Gibson
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, Pro Hac Vice, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0443893301&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Rachel Elsby
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, Pro Hac Vice, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0326980101&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Steven D. Maslowski
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, Pro Hac Vice, for Plaintiff.
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0418029101&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Andrew Colin Mayo
}}}
\sb200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0338332501&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
John G. Day
}}}
\sb200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, Ashby & Geddes, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0177211801&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Michael P. Kelly
}}}
\sb200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0444922201&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Benjamin A. Smyth
}}}
\sb200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0359097501&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Daniel M. Silver
}}}
\sb200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, McCarter & English, LLP, Wilmington, DE, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0165991901&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
David T. Pritikin
}}}
\sb200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, Pro Hac Vice, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0447795701&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Fitz B. Collings
}}}
\sb200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, Pro Hac Vice, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0489702799&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Grace I. Chiang
}}}
\sb200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, Pro Hac Vice, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0426813601&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Gwen Stewart
}}}
\sb200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, Pro Hac Vice, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0280179401&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Jeffrey P. Kushan
}}}
\sb200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, Pro Hac Vice, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0489686299&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Kirsten E. Braun
}}}
\sb200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, Pro Hac Vice, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0489704599&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Lauren C. Cranford
}}}
\sb200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, Pro Hac Vice, Lisa A. Schneider, Pro Hac Vice, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0329040801&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Michael D. Hatcher
}}}
\sb200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, Pro Hac Vice, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0260634401&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Todd L. Krause
}}}
\sb200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, Pro Hac Vice, 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0205432501&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
William H. Baumgartner, Jr.
}}}
\sb200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb200 
, Pro Hac Vice, for Defendant.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf21 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_opinion_61}{\*\bkmkend co_opinion_61}
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_If21ce1721a1011eb8a05d959257df}{\*\bkmkend co_anchor_If21ce1721a1011eb8a05d959257df}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_If22a4ef11a1011eb8a05d959257df}{\*\bkmkend co_anchor_If22a4ef11a1011eb8a05d959257df}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_If22a4ef11a1011eb8a05d959257df}{\*\bkmkend co_anchor_If22a4ef11a1011eb8a05d959257df}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \i1 \fs20 
{\b1 \cf1 \f2 \i1 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa200 \sb800 
ORDER
\par 
}
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=h&pubNum=176284&cite=0132747001&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
GREGORY M. SLEET
}}}
\sa200 
\sb200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa200 \sb200 
, UNITED STATES DISTRICT JUDGE
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_999_1_61}{\*\bkmkend co_pp_sp_999_1_61}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*1
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 WHEREAS, on July 7, 2015, the plaintiff Bristol\u8211\'3fMyers Squibb Co., E.R. Squibb & Sons, L.L.C., Ono Pharmaceutical CO., LTD., and Tasuku Honjo (collectively \u8220\'3fBristol\u8211\'3fMyers\u8221\'3f) filed this patent infringement action against the defendant Merck & Co., Inc. and Merck Sharp & Dohme Corp., (collectively \u8220\'3fMerck\u8221\'3f). (D.I.1)
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_B00012038753187_ID0E3JAC_61}{\*\bkmkend co_fnRef_B00012038753187_ID0E3JAC_61}
{\field {\*\fldinst HYPERLINK "#co_footnote_B00012038753187_61" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
1
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
;
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
WHEREAS, presently before the court is Merck\rquote s Motion to Dismiss the Complaint. (D.I. 5, 6);
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
WHEREAS, the court having considered the motion, the parties\rquote  positions as set forth in their papers, as well as the applicable law;
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
IT IS HEREBY ORDERED THAT:
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li200 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb400 
Merck\rquote s Motion to Dismiss the Complaint (D.I.5) is DENIED.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_B00022038753187_ID0EJMAC_61}{\*\bkmkend co_fnRef_B00022038753187_ID0EJMAC_61}
{\field {\*\fldinst HYPERLINK "#co_footnote_B00022038753187_61" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
2
}}}
\sb200 
\par 
}
}
}
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf21 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_allCitations_61}{\*\bkmkend co_allCitations_61}
{\b1 \cf21 \f2 \ul0 \strike0 \i0 \fs20 \sa200 \sb200 
All Citations
\par 
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Not Reported in Fed. Supp., 2016 WL 1698385
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
}
}
{\b0 \cf1 \f4 \ri0 \i0 \ql \fs24 \li0 \par}\sect\sbknone\pgncont\cols1{\ids0 {
{\trowd \ltrrow \trleft0 
\clpadl200 \clpadfl3 \clbrdrt \clbrdrl \trql \clwWidth10080 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \ql \fs20 \li0 
{\b0 \cf1 \f4 \i0 \fs20 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Footnotes
\par 
}
}
}
}\b0 \cf1 \f4 \ri0 \ul0 \strike0 \i0 \ql \li0 \fs20 \sa0 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \ql \fs24 \li0 
{\b0 \cf1 \f4 \i0 \fs24 
{\*\bkmkstart co_footnote_B00012038753187_61}{\*\bkmkend co_footnote_B00012038753187_61}
{\field {\*\fldinst HYPERLINK "#co_fnRef_B00012038753187_ID0E3JAC_61" }{\fldrslt 
{\super \b0 \cf19 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
1
}\super \b0 \cf19 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f4 \ri0 \i0 \ql \li0 \fs24 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Bristol\u8211\'3fMyers alleges that Merck induces or contributes to infringement of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036662908&pubNum=0004074&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=PA&docFamilyGuid=I12973c90272611e5a200c58a628f9a0b&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
United States Patent No. 9,073,994 (\u8220\'3fthe \lquote 994 Patent\u8221\'3f)
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 by making and selling pembrolizumab, which Merck sells in the United States under the name Keytruda\u174\'3f for the treatment of patients with 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Ibd1c6021475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
melanoma
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
. (D.I. 1 at \u182\'3f\u182\'3f 19\u8211\'3f25, 29.)
\par 
}
}
}
}
}\b0 \cf1 \f4 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa0 \sb0 \intbl \cell \row }
{\trowd \lastrow \trleft0 
\clbrdrb \clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clbrdrb \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \ql \fs24 \li0 
{\b0 \cf1 \f4 \i0 \fs24 
{\*\bkmkstart co_footnote_B00022038753187_61}{\*\bkmkend co_footnote_B00022038753187_61}
{\field {\*\fldinst HYPERLINK "#co_fnRef_B00022038753187_ID0EJMAC_61" }{\fldrslt 
{\super \b0 \cf19 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
2
}\super \b0 \cf19 \f4 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f4 \ri0 \i0 \ql \li0 \fs24 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Federal Rule of Civil Procedure 12(b)(6)
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 provides for dismissal where the plaintiff \u8220\'3ffail[s] to state a claim upon which relief can be granted.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Fed.R.Civ.P. 12(b)(6)
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
. \u8220\'3fThreadbare recitals of the elements of a cause of action, supported by mere conclusory statements,\u8221\'3f are inadequate to state a claim. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2018848474&pubNum=0000780&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RP&fi=co_pp_sp_780_678&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_678" }{\fldrslt 
{\b0 \cf19 \f4 \i1 \fs18 
{\b0 \cf19 \f4 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Ashcroft v. Iqbal,
}
}
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 556 U.S. 662, 678 (2009)
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
. In considering a motion to dismiss, the court \u8220\'3faccept[s] all factual allegations as true, construe[s] the complaint in the light most favorable to the plaintiff, and determine[s] whether, under any reasonable reading of the complaint, the plaintiff may be entitled to relief.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2015125207&pubNum=0000506&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RP&fi=co_pp_sp_506_233&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_233" }{\fldrslt 
{\b0 \cf19 \f4 \i1 \fs18 
{\b0 \cf19 \f4 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Phillips v. Cnty. of Allegheny,
}
}
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 515 F.3d 224, 233 (3d Cir.2008)
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
.
\par 
}
}
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Merck argues that the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036662908&pubNum=0004074&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=PA&docFamilyGuid=I12973c90272611e5a200c58a628f9a0b&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 994 Patent
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 claims ineligible subject matter pursuant to 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf20 \f4 \i0 \fs18 \chcbpat26 
{\b1 \cf20 \f4 \i0 \fs18 \chcbpat26 
{\b1 \cf20 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
35
}
}
}
{\b0 \cf19 \f4 \i0 \fs18 \chcbpat2 
}
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 U.S.C. 
}
{\b1 \cf20 \f4 \i0 \fs18 \chcbpat26 
{\b1 \cf20 \f4 \i0 \fs18 \chcbpat26 
{\b1 \cf20 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\u167\'3f
}
}
}
{\b0 \cf19 \f4 \i0 \fs18 \chcbpat2 
}
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b1 \cf20 \f4 \i0 \fs18 \chcbpat26 
{\b1 \cf20 \f4 \i0 \fs18 \chcbpat26 
{\b1 \cf20 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
101
}
}
}
{\b0 \cf19 \f4 \i0 \fs18 \chcbpat2 
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \chcbpat2 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
. (D.I. 6 at 10\u8211\'3f11.) According to Merck, the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036662908&pubNum=0004074&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=PA&docFamilyGuid=I12973c90272611e5a200c58a628f9a0b&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 994 Patent
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 is directed to a natural phenomenon and the patent claims do not transform such natural phenomenon into a patent-eligible invention because the claims contain no inventive concept. (
}
{\b0 \cf1 \f4 \i1 \fs18 
{\b0 \cf1 \f4 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
) Merck asserts that the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036662908&pubNum=0004074&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=PA&docFamilyGuid=I12973c90272611e5a200c58a628f9a0b&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 994 patent
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 claims that the natural phenomenon is the body\rquote s own mechanism for regulating the immune system.
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b0 \cf1 \f4 \i1 \fs18 
{\b0 \cf1 \f4 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
(
}
}
{\b0 \cf1 \f4 \i1 \fs18 
{\b0 \cf1 \f4 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 at 6.) Specifically, T cells, which are part of the immune system, attack and kill cells that the immune system sees as foreign, such as 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Iaf34f5c3475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
cancer
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 cells. (
}
{\b0 \cf1 \f4 \i1 \fs18 
{\b0 \cf1 \f4 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
) Merck claims that the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036662908&pubNum=0004074&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=PA&docFamilyGuid=I12973c90272611e5a200c58a628f9a0b&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 994 patent
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 recites no inventive contribution beyond the natural phenomenon itself. (
}
{\b0 \cf1 \f4 \i1 \fs18 
{\b0 \cf1 \f4 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 at 2). Thus, according to Merck, the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036662908&pubNum=0004074&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=PA&docFamilyGuid=I12973c90272611e5a200c58a628f9a0b&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 994 patent
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 covers a patent ineligible subject matter. 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027337692&pubNum=0000708&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RP&fi=co_pp_sp_708_1298&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_1298" }{\fldrslt 
{\b0 \cf19 \f4 \i1 \fs18 
{\b0 \cf19 \f4 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Mayo Collaborative Servs. v. Prometheus Labs., Inc.,
}
}
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 132 S.Ct. 1289, 1298 (2012)
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
. A patent infringement claim that asserts infringement of claims that are invalid fails to state a claim on which relief can be granted. Therefore, Merck asserts that Bristol\u8211\'3fMyers\rquote  infringement claims should be dismissed with prejudice. (D.I. 6 at 19\u8211\'3f20.)
\par 
}
}
}
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Bristol\u8211\'3fMyers responds that the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036662908&pubNum=0004074&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=PA&docFamilyGuid=I12973c90272611e5a200c58a628f9a0b&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 994 patent
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 is a method of treatment claim that merely relies on the human body\rquote s ability to respond to the disease. (D.I. 15 at 2.) Bristol\u8211\'3fMyers further asserts that Merck\rquote s argument \u8220\'3fmisses the point that 
}
{\b0 \cf1 \f4 \i1 \fs18 
{\b0 \cf1 \f4 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
every
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 method of therapeutic treatment at its basic level relies on the biological activity of the patient\rquote s immune system.\u8221\'3f 
}
{\b0 \cf1 \f4 \i1 \fs18 
{\b0 \cf1 \f4 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
(
}
}
{\b0 \cf1 \f4 \i1 \fs18 
{\b0 \cf1 \f4 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 at 9). According to Bristol\u8211\'3fMyers, the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036662908&pubNum=0004074&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=PA&docFamilyGuid=I12973c90272611e5a200c58a628f9a0b&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 994 patent
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 relies on the body\rquote s immune system via the PD\u8211\'3f1 pathway, but adds the step of administering a composition of anti\u8211\'3fPD\u8211\'3f1 antibodies for the treatment of 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Ib7c7f00c475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
metastatic melanoma
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 to induce an immune response that would not otherwise occur in the patient\rquote s natural state. (D.I. 15 at 17).
\par 
}
}
}
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf20 \f4 \i0 \fs18 \chcbpat26 
{\b1 \cf20 \f4 \i0 \fs18 \chcbpat26 
{\b1 \cf20 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Section
}
}
}
{\b0 \cf19 \f4 \i0 \fs18 \chcbpat2 
}
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b1 \cf20 \f4 \i0 \fs18 \chcbpat26 
{\b1 \cf20 \f4 \i0 \fs18 \chcbpat26 
{\b1 \cf20 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
101
}
}
}
{\b0 \cf19 \f4 \i0 \fs18 \chcbpat2 
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \chcbpat2 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 describes the general categories of patentable subject matter as \u8220\'3fany new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf20 \f4 \i0 \fs18 \chcbpat26 
{\b1 \cf20 \f4 \i0 \fs18 \chcbpat26 
{\b1 \cf20 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
35
}
}
}
{\b0 \cf19 \f4 \i0 \fs18 \chcbpat2 
}
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 U.S.C. 
}
{\b1 \cf20 \f4 \i0 \fs18 \chcbpat26 
{\b1 \cf20 \f4 \i0 \fs18 \chcbpat26 
{\b1 \cf20 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\u167\'3f
}
}
}
{\b0 \cf19 \f4 \i0 \fs18 \chcbpat2 
}
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b1 \cf20 \f4 \i0 \fs18 \chcbpat26 
{\b1 \cf20 \f4 \i0 \fs18 \chcbpat26 
{\b1 \cf20 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
101
}
}
}
{\b0 \cf19 \f4 \i0 \fs18 \chcbpat2 
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \chcbpat2 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
. There are, however, exceptions to these broad classifications. \u8220\'3fLaws of nature, natural phenomena, and abstract ideas are not patentable.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&pubNum=0000708&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RP&fi=co_pp_sp_708_2354&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2354" }{\fldrslt 
{\b0 \cf19 \f4 \i1 \fs18 
{\b0 \cf19 \f4 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Alice,
}
}
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 134 S.Ct. at 2354
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 (quoting 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2030717666&pubNum=0000708&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RP&fi=co_pp_sp_708_2216&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2216" }{\fldrslt 
{\b0 \cf19 \f4 \i1 \fs18 
{\b0 \cf19 \f4 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Ass\rquote n for Molecular Pathology v. Myriad Genetics, Inc.,
}
}
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 133 S.Ct. 2107, 2216 (2013)
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
). The contours of these exceptions have been the subject of much debate in recent years. 
}
{\b0 \cf1 \f4 \i1 \fs18 
{\b0 \cf1 \f4 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See id.
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 (\u8220\'3f[W]e tread carefully in construing this exclusionary principle lest it swallow all of patent law. At some level, all inventions ... embody, use, reflect, rest upon, or apply laws of nature, natural phenomena, or abstract ideas.\u8221\'3f (internal citation and quotations marks omitted)).
\par 
}
}
}
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
The Supreme Court\rquote s decision in 
}
{\b0 \cf1 \f4 \i1 \fs18 
{\b0 \cf1 \f4 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Alice
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 reaffirmed the framework first outlined in 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027337692&pubNum=0000708&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f4 \i1 \fs18 
{\b0 \cf19 \f4 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Mayo Collaborative Services v. Prometheus Laboratories, Inc.,
}
}
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 132 S.Ct. 1289 (2012)
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, used to \u8220\'3fdistinguish[ ] patents that claim laws of nature, natural phenomena, and abstract ideas from those that claim patent\u8211\'3feligible applications of those concepts.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&pubNum=0000708&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RP&fi=co_pp_sp_708_2355&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2355" }{\fldrslt 
{\b0 \cf19 \f4 \i1 \fs18 
{\b0 \cf19 \f4 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Alice,
}
}
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 134 S.Ct. at 2355
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
.
\par 
}
}
}
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li180 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
First, we determine whether the claims at issue are directed to one of those patent-ineligible concepts. If so, we then ask, what else is there in the claims before us? To answer that question, we consider the elements of each claim both individually and as an ordered combination to determine whether the additional elements transform the nature of the claim into a patent-eligible application.
\par 
}
}
}
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \i1 \fs18 
{\b0 \cf1 \f4 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
(internal citations, quotations marks, and alterations omitted). Thus, the court must determine (1) if the patented technology touches upon ineligible subject matter, and (2) whether there are sufficient inventive elements such that the invention is \u8220\'3f \lquote significantly more\rquote  than a patent on an ineligible concept.\u8221\'3f 
}
{\b0 \cf1 \f4 \i1 \fs18 
{\b0 \cf1 \f4 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See 
}
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2034937126&pubNum=0000506&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RP&fi=co_pp_sp_506_1255&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1255" }{\fldrslt 
{\b0 \cf19 \f4 \i1 \fs18 
{\b0 \cf19 \f4 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
DDR Holdings, LLC v. Hotels.com, L.P.,
}
}
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 773 F.3d 1245, 1255 (Fed.Cir.2014)
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 (quoting 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&pubNum=0000708&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RP&fi=co_pp_sp_708_2355&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2355" }{\fldrslt 
{\b0 \cf19 \f4 \i1 \fs18 
{\b0 \cf19 \f4 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Alice,
}
}
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 134 S.Ct. at 2355
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
); 
}
{\b0 \cf1 \f4 \i1 \fs18 
{\b0 \cf1 \f4 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
see also 
}
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2033619398&pubNum=0000708&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RP&fi=co_pp_sp_708_2354&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_2354" }{\fldrslt 
{\b0 \cf19 \f4 \i1 \fs18 
{\b0 \cf19 \f4 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Alice,
}
}
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 134 S.Ct. at 2354
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 (\u8220\'3f[A]n invention is not rendered ineligible for patent simply because it involves an abstract concept.\u8221\'3f
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
).
\par 
}
}
}
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
The 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036662908&pubNum=0004074&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=PA&docFamilyGuid=I12973c90272611e5a200c58a628f9a0b&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 994 patent
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 claims treatment for 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Ib7c7f00c475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
metastatic melanoma
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 in humans by intravenously administering an effective amount of a composition comprising a human or humanized anti-PD1 monoclonal antibody and a solubilizer in a solution. (D.I. 1\u8211\'3f1 at col. 25:22\u8211\'3f27.) The 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036662908&pubNum=0004074&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=PA&docFamilyGuid=I12973c90272611e5a200c58a628f9a0b&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 994 patent
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 relies on the scientific fact that blocking activation of the PD\u8211\'3f1 pathway enables the patient\rquote s T cells to perform their normal biological activity of removing 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Iaf34f5c3475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
cancer
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 cells. (D.I. 1 at \u182\'3f 5.) By preventing PD\u8211\'3f1 ligands from binding to the PD\u8211\'3f1 receptor, the anti\u8211\'3fPD\u8211\'3f1 antibodies prevent the PD\u8211\'3f1 pathway from suppressing the immune system, which, in turn, kills and clears the body of the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Iaf34f5c3475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
cancer
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 cells. (
}
{\b0 \cf1 \f4 \i1 \fs18 
{\b0 \cf1 \f4 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
)
\par 
}
}
}
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li360 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
First, the court concludes that, contrary to Bristol\u8211\'3fMyers contention, (D.I. 15 at 8), the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036662908&pubNum=0004074&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=PA&docFamilyGuid=I12973c90272611e5a200c58a628f9a0b&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 994 patent
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 touches upon a natural phenomenon by using T cells to activate the immune system. The 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036662908&pubNum=0004074&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=PA&docFamilyGuid=I12973c90272611e5a200c58a628f9a0b&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 994 patent
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 relies on the known scientific fact that blocking activation of the PD\u8211\'3f1 pathway causes this effect in the body, which enables the patient\rquote s T cells to perform their normal biological activity of removing 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?entityType=disease&entityId=Iaf34f5c3475411db9765f9243f53508a&originationContext=document&transitionType=DocumentItem&contextData=(sc.Default)&vr=3.0&rs=cblt1.0" }{\fldrslt 
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
cancer
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 cells. (D.I. 1 at \u182\'3f 5.) This interaction is a natural phenomenon.
\par 
}
}
}
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Thus, the remaining question before the court is \u8220\'3fwhether the claims do significantly more than simply describe these natural relations. To put the matter more precisely, do the patent claims add 
}
{\b0 \cf1 \f4 \i1 \fs18 
{\b0 \cf1 \f4 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
enough
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 to their statements of the correlations to allow the processes they describe to qualify as patent-eligible processes that 
}
{\b0 \cf1 \f4 \i1 \fs18 
{\b0 \cf1 \f4 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
apply
}
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 natural laws?\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2027337692&pubNum=0000708&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RP&fi=co_pp_sp_708_1297&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_708_1297" }{\fldrslt 
{\b0 \cf19 \f4 \i1 \fs18 
{\b0 \cf19 \f4 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Mayo Collaborative Servs. v. Prometheus Labs., Inc.,
}
}
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 132 S.Ct. 1289, 1297 (2012)
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
.
\par 
}
}
}
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
When the factual allegations in the patent are taken as true and read in the light most favorable to Bristol\u8211\'3fMyers, there are, at the very least, material factual disputes that cannot be resolved on a motion to dismiss. Merck contends that the process method consists of administering a synthetic substance through a single step to induce a natural reaction. (D.I. 6 at 13.) Bristol\u8211\'3fMyers insists that administering anti-PD1 antibodies is not a diagnostic step, but provides the treatment itself. (D.I. 15 at 10\u8211\'3f14.) Whether the claims amount to an implementation step is a complicated factual determination that the court could better resolve after discovery. (D.I. 15 at 15.)
\par 
}
}
}
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Additionally, the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036662908&pubNum=0004074&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=PA&docFamilyGuid=I12973c90272611e5a200c58a628f9a0b&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 994 patent
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 is entitled to a presumption of validity under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS282&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf20 \f4 \i0 \fs18 \chcbpat26 
{\b1 \cf20 \f4 \i0 \fs18 \chcbpat26 
{\b1 \cf20 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
35
}
}
}
{\b0 \cf19 \f4 \i0 \fs18 \chcbpat2 
}
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 U.S.C. \u167\'3f 282
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \chcbpat2 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
. (D.I. 15 at 13.) Rarely can a patent infringement suit be dismissed at the pleading stage for lack of patentable subject matter. 
}
{\b0 \cf1 \f4 \i1 \fs18 
{\b0 \cf1 \f4 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See 
}
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2034294046&pubNum=0000999&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f4 \i1 \fs18 
{\b0 \cf19 \f4 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Tuxis Techs., LLC v. Amazon.com, Inc.,
}
}
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 No. 13\u8211\'3f1771\u8211\'3fRGA, 2014 WL 4382446, at *2 (D.Del. Sept. 3, 2014)
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
. (\u8220\'3fAt the motion to dismiss stage, a patent claim can be found directed towards patent-ineligible subject matter if the only plausible reading of the patent must be that there is clear and convincing evidence of ineligibility.\u8221\'3f) Here, the determination of the Patent Office that the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036662908&pubNum=0004074&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=PA&docFamilyGuid=I12973c90272611e5a200c58a628f9a0b&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 994 Patent
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 was patent-eligible is presumed to be correct.
\par 
}
}
}
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Pursuant to 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Federal Rule of Civil Procedure 12(b)(6)
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, and after having considered the pleadings in the light most favorable to the Bristol\u8211\'3fMyers, the court concludes that Merck has not met its burden to prove by clear and convincing evidence that the 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2036662908&pubNum=0004074&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=PA&docFamilyGuid=I12973c90272611e5a200c58a628f9a0b&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\rquote 994 Patent
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 is invalid on its face for failing to cover patent-eligible subject matter under 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=35USCAS101&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b1 \cf20 \f4 \i0 \fs18 \chcbpat26 
{\b1 \cf20 \f4 \i0 \fs18 \chcbpat26 
{\b1 \cf20 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
35
}
}
}
{\b0 \cf19 \f4 \i0 \fs18 \chcbpat2 
}
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 U.S.C. 
}
{\b1 \cf20 \f4 \i0 \fs18 \chcbpat26 
{\b1 \cf20 \f4 \i0 \fs18 \chcbpat26 
{\b1 \cf20 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\u167\'3f
}
}
}
{\b0 \cf19 \f4 \i0 \fs18 \chcbpat2 
}
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b1 \cf20 \f4 \i0 \fs18 \chcbpat26 
{\b1 \cf20 \f4 \i0 \fs18 \chcbpat26 
{\b1 \cf20 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
101
}
}
}
{\b0 \cf19 \f4 \i0 \fs18 \chcbpat2 
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \chcbpat2 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
. If 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Rule 12(b)(6)
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 is used to assert an affirmative defense, dismissal is appropriate only if the well-pleaded factual allegations in the complaint, construed in the light most favorable to the plaintiff, suffice to establish the defense.
}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Here there is not clear and convincing evidence that ineligibility is the only plausible reading of the patent. For the reasons stated above, the court concludes that Merck has not met its burden. Accordingly, the court must deny Merck\rquote s 
}
{\field {\*\fldinst HYPERLINK "http://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000600&cite=USFRCPR12&originatingDoc=Id61a54a00dcf11e6a647af7ccdd8c5d2&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Rule 12(b)(6)
}\b0 \cf19 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f4 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Motion to Dismiss. (D.I.5.)
\par 
}
}
}
}
}
}\b0 \cf1 \f4 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa0 \sb0 \intbl \cell \row }}\par 
}
{\b0 \cf1 \f2 \ri0 \par}\sect\sbknone\pgncont\cols2{\ids0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
}
}
{\b0 \cf1 \f4 \ri0 \i0 \ql \fs24 \li0 \par}\sect\sbknone\pgncont\cols1{\ids0 {
{\trowd \lastrow \trleft0 
\clpadt24 \clpadft3 \clpadl100 \clpadfl3 \clpadr24 \clpadfr3 \clbrdrt \brdrcf22 \brdrw10 \brdrs \clbrdrb \clbrdrl \trql \clvertalt \clwWidth4320 \cellx4320 
\clpadt29 \clpadft3 \clpadl100 \clpadfl3 \clpadr29 \clpadfr3 \clbrdrt \brdrcf22 \brdrw10 \brdrs \clbrdrb \clbrdrr \trql \clvertalt \clwWidth5760 \cellx10080 
\intbl 
{\ri24 \li24 
{\b1 \cf22 \f4 \ri24 \i0 \ql \fs16 \li24 
{\b1 \cf22 \f4 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
End of Document
\par 
}
}
}\b1 \cf22 \f4 \ri24 \ul0 \strike0 \i0 \ql \li24 \fs16 \sa0 \sb0 \intbl \cell \intbl 
{\ri29 \li29 
{\qr \b0 \cf22 \f4 \ri29 \i0 \fs19 \li29 
{\b0 \cf22 \f4 \ul0 \strike0 \i0 \fs19 \sa0 \sb0 
\u169\'3f 2021 Thomson Reuters. No claim to original U.S. Government Works.
\par 
}
}
}\qr \b0 \cf22 \f4 \ri29 \ul0 \strike0 \i0 \li29 \fs19 \sa0 \sb0 \intbl \cell \row }}\par 
}
{\b0 \cf1 \f2 \ri0 \par}\sect\sbknone\pgncont\cols2{\ids0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
}
}\sect }